Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FGF23 associated bone diseases.

Literature DB >> 23471660

FGF23 associated bone diseases.

Abstract

Recently, fibroblast growth factor 23 (FGF23) has sparked widespread interest because of its potential role in regulating phosphate and vitamin D metabolism. In this review, we summarized the FGF superfamily, the mechanism of FGF23 on phosphate and vitamin D metabolism, and the FGF23 related bone disease.

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 2013 PMID： 23471660 DOI： 10.1007/s11684-013-0254-6

Source DB: PubMed Journal: Front Med ISSN： 2095-0217 Impact factor: 4.592

62 in total

Review 1. Regulation of vitamin D metabolism.

Authors: Helen L Henry
Journal: Best Pract Res Clin Endocrinol Metab Date: 2011-08 Impact factor: 4.690

Review 2. Management of osteoporosis in CKD Stages 3 to 5.

Authors: Patricia L Gordon; Lynda A Frassetto
Journal: Am J Kidney Dis Date: 2010-05 Impact factor: 8.860

3. Tumor-induced osteomalacia (TIO): atypical presentation.

Authors: Waseem Khaliq; Praveen Cheripalli; Krishnarao Tangella
Journal: South Med J Date: 2011-05 Impact factor: 0.954

Review 4. Phosphate transport in the kidney.

Authors: Heini Murer; Jürg Biber
Journal: J Nephrol Date: 2010 Nov-Dec Impact factor: 3.902

Review 5. Fibroblast growth factor 23 as a phosphotropic hormone and beyond.

Authors: Seiji Fukumoto; Yuichiro Shimizu
Journal: J Bone Miner Metab Date: 2011-08-06 Impact factor: 2.626

Review 6. Novel PHEX nonsense mutation in a patient with X-linked hypophosphatemic rickets and review of current therapeutic regimens.

Authors: T Kienitz; M Ventz; E Kaminsky; M Quinkler
Journal: Exp Clin Endocrinol Diabetes Date: 2011-05-06 Impact factor: 2.949

7. alpha-Klotho as a regulator of calcium homeostasis.

Authors: Akihiro Imura; Yoshihito Tsuji; Miyahiko Murata; Ryota Maeda; Koji Kubota; Akiko Iwano; Chikashi Obuse; Kazuya Togashi; Makoto Tominaga; Naoko Kita; Ken-ichi Tomiyama; Junko Iijima; Yoko Nabeshima; Makio Fujioka; Ryo Asato; Shinzo Tanaka; Ken Kojima; Juichi Ito; Kazuhiko Nozaki; Nobuo Hashimoto; Tetsufumi Ito; Takeshi Nishio; Takashi Uchiyama; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal: Science Date: 2007-06-15 Impact factor: 47.728

3. Twist1-Haploinsufficiency Selectively Enhances the Osteoskeletal Capacity of Mesoderm-Derived Parietal Bone Through Downregulation of Fgf23.

Authors: Natalina Quarto; Siny Shailendra; Nathaniel P Meyer; Siddharth Menon; Andrea Renda; Michael T Longaker
Journal: Front Physiol Date: 2018-10-15 Impact factor: 4.566

3 in total

FGF23 associated bone diseases.

Review 1. Regulation of vitamin D metabolism.

Review 2. Management of osteoporosis in CKD Stages 3 to 5.

3. Tumor-induced osteomalacia (TIO): atypical presentation.

Review 4. Phosphate transport in the kidney.

Review 5. Fibroblast growth factor 23 as a phosphotropic hormone and beyond.

Review 6. Novel PHEX nonsense mutation in a patient with X-linked hypophosphatemic rickets and review of current therapeutic regimens.

7. alpha-Klotho as a regulator of calcium homeostasis.

8. Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides.

Review 9. Regulation of phosphate transport in proximal tubules.

10. The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment.

Review 1. Fibroblast growth factor signaling in skeletal development and disease.

Review 2. Vitamin D deficiency in India: prevalence, causalities and interventions.

3. Twist1-Haploinsufficiency Selectively Enhances the Osteoskeletal Capacity of Mesoderm-Derived Parietal Bone Through Downregulation of Fgf23.